Multicentre assessment and monitored use of [(18)F]FDG-PET in oncology: the Spanish experience.
Eur J Nucl Med Mol Imaging. 2007 Oct 3
Rodriguez-Garrido M., Asensio-Del-Barrio C.

Estimad@ Soci@:
Me es grato ponerme en contacto para enviarle la convocatoria para una plaza de médico especialista en Medicina Nuclear, que hemos colgado en nuestra
web:
http://www.semn.es/buscar/bolsa.htm
Espero que sea de su interés, reciba un cordial saludo, Mar Pérez Villalba Secretaría SEMN C/Capitán Haya,60 28020 Madrid
Tlf.:91 749 95 17
Fax: 91 570 89 11

Evidence-based medicine

Adjunto interesante referencia sobre articulo publicado en DM. Si alguien ha sido sometido a MBE, esa ha sido la tecnología PET.

http://www.diariomedico.com/blogs/laboratorio/

ACCP Evidenced-Based Clinical Practice Guidelines

Invasive Mediastinal Staging of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Detterbeck, F. C., Jantz, M. A., Wallace, M., Vansteenkiste, J., Silvestri, G. A.
Chest 2007 132: p. 202S-220S
http://www.chestjournal.org/cgi/content/abstract/132/3_suppl/202S?ct
--------------------
Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Silvestri, G. A., Gould, M. K., Margolis, M. L., Tanoue, L. T., McCrory, D., Toloza, E., Detterbeck, F.
Chest 2007 132: p. 178S-201S
http://www.chestjournal.org/cgi/content/abstract/132/3_suppl/178S?ct

El Meixoeiro instalará un equipo que detecta tumores antes de que se formen
http://www.farodevigo.es/secciones/noticia.jsp?pRef=3110_2_162775__Gran_Vigo-Meixoeiro-instalara-equipo-detecta-tumores-antes-formen

Güemes impulsa el tratamiento radiológico en la sanidad pública

Los cinco nuevos aparatos de PET adquiridos por la Comunidad de Madrid sitúan a la región a la cabeza de España con el mayor número de unidades de titularidad pública, y al nivel de otros países europeos con una tasa de un equipo público por cada millón de habitantes.

Lo referente a esta noticia aparecida en la edicion de hoy de DM está disponible en: http://pet-ct.blogspot.com/

Evaluation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: A PET CT study.
Nucl Med Commun. 2007 Sep;28(9):675-80.
Wong W.L., Gibson D., Sanghera B., Goodchild K., Saunders M.
aPaul Strickland Scanner Centre bMarie Curie Research Wing for Oncology, Mount Vernon Hospital, Northwood, Middlesex, UK.
OBJECTIVE: The aims of the study were to (1) evaluate the range of physiological FDG uptake in normal pharyngeal palatine tonsil, and (2) investigate the possibility of establishing a cut-off threshold to distinguish between normal pharyngeal palatine tonsil FDG uptake from occult pharyngeal palatine tonsil primary cancer. METHODS: FDG PET CT of 43 consecutive patients with a low risk of head and neck cancer were reviewed by two observers. Axial PET CT was used to identify foci of FDG uptake related to the pharyngeal palatine tonsil. The highest standardized uptake value, SUVmax, of the left and right pharyngeal palatine tonsil was calculated. Similar analysis was performed on 10 consecutive patents with histologically proven occult pharyngeal palatine tonsil primary cancer. RESULTS: The mean SUVmax of the 43 right pharyngeal palatine tonsils was 4.82 (range, 1.16-12.74) and 4.68 (range, 0.88-13.65) for the 43 left pharyngeal palatine tonsils with no statistical difference observed (P=0.4). Normal pharyngeal palatine tonsil uptake was generally symmetrical and there was a positive correlation between SUVmax from the left and right sides which was statistically significant (r=0.9, P<0.0001).>